Rockefeller Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38 Hold
8
﹤0.01% 4652
2025
Q4
$145 Hold
8
﹤0.01% 4610
2025
Q3
$115 Buy
+8
New +$92 ﹤0.01% 4371
2023
Q3
Sell
-2,157
Closed -$86.8K 1505
2023
Q2
$86.8K Hold
2,157
﹤0.01% 1785
2023
Q1
$156K Hold
2,157
﹤0.01% 1856
2022
Q4
$176K Hold
2,157
﹤0.01% 1721
2022
Q3
$203K Buy
2,157
+420
+24% +$47.2K ﹤0.01% 1645
2022
Q2
$338K Buy
1,737
+200
+13% +$32.6K ﹤0.01% 1427
2022
Q1
$356K Sell
1,537
-20
-1% -$6.37K ﹤0.01% 1457
2021
Q4
$613K Buy
1,557
+37
+2% +$15.6K ﹤0.01% 1245
2021
Q3
$680K Buy
1,520
+590
+63% +$211K ﹤0.01% 1147
2021
Q2
$361K Sell
930
-300
-24% -$107K ﹤0.01% 1318
2021
Q1
$441K Buy
1,230
+330
+37% +$146K ﹤0.01% 1060
2020
Q4
$441K Hold
900
﹤0.01% 952
2020
Q3
$291K Buy
+900
New +$306K ﹤0.01% 937

Other funds holding ATRA